A importância do cirurgião-dentista no tratamento de pacientes com mieloma múltiplo: relato de caso

Pâmela de Oliveira Andrade; Lucas  dos Santos Viero; Silvia Elena Navas Alfaro

doi:10.24859/SaberDigital.2026v19n2.1668

Authors

Pâmela de Oliveira Andrade Centro Universitário de Valença - UNIFAA https://orcid.org/0009-0008-8606-1280
Lucas dos Santos Viero Centro Universitário de Valença - UNIFAA https://orcid.org/0009-0002-8106-0453
Silvia Elena Navas Alfaro Centro Universitário de Valença - UNIFAA https://orcid.org/0009-0001-1103-1633

DOI:

https://doi.org/10.24859/SaberDigital.2026v19n2.1668

Keywords:

Interdisciplinary Health Team, Oral Health, Dentistry, Oncology

Abstract

ABSTRACT: Introduction: Multiple myeloma (MM) is a malignant disease of plasma cells that affects the bone marrow. Early diagnosis and appropriate treatment, which involves chemotherapy, radiotherapy and bone marrow transplantation (BMT), are essential for a good prognosis. The oral manifestations of MM include pain, swelling and lesions, and the role of the dental surgeon (DS) is essential at all stages of treatment. Case Report: The 69-year-old male patient initially sought medical attention due to pain in the lumbar region and was diagnosed with a herniated disc. After complementary examinations, he was diagnosed with MM and began treatment with chemotherapy and radiotherapy. During the dental assessment to receive a report for the BMT, the DS identified procedures that needed to be carried out, but which

were not possible due to the patient's age limit for the transplant and the use of Zometa®. Discussion: The DS's participation is crucial to avoid oral complications during cancer treatment. The absence of adequate dental care can cause serious complications such as osteonecrosis after tooth extraction, especially when bisphosphonates such as Zometa® are used. Collaboration between doctors and dentists is essential to ensure the patient's overall health. Conclusion: The DS's intervention in the treatment of MM is indispensable at all stages, prevents complications and improves the patient's quality of life. Cooperation between health professionals and awareness of dental care are essential to optimize treatment results.

Downloads

Download data is not yet available.

References

ALI, I. K. et al. Multiple myeloma with primary manifestation in the mandible.

Cureus, v. 10, n. 3, 2018.

ANDERSON, K. C. et al. Multiple Myeloma: New Insights and Therapeutic Approaches. Hematology, v. 2000, n. 1, p. 147–165, 1 jan. 2000.

ALMEIDA, T. M. X. DE et al. Can dentists detect multiple myeloma through oral manifestations? Hematology, transfusion and cell therapy, v. 40, n. 1, p. 43–49, 2018.

ARAÚJO, B. A. et al. O IMPACTO DA LASERTERAPIA NA MUCOSITE

ORAL. Revista Uningá, v. 55, n. S3, p. 39–46, 20 dez. 2018.

BAROSI, GIOVANNI et al. Management of multiple myeloma and related-disorders: guidelines from the Italian Society of Hematology (SIE), Italian Society of Experimental Hematology (SIES) and Italian Group for Bone Marrow Transplantation (GITMO). haematologica, v. 89, n. 6, p. 717-741, 2004.

BEECH, N. et al. Dental management of patients irradiated for head and neck cancer. Australian Dental Journal, v. 59, n. 1, p. 20–28, 4 fev. 2014.

BRASIL. Ministério da Saúde. Diretrizes Diagnósticas e Terapêuticas do Mieloma Múltiplo. Brasília, DF: Ministério da Saúde, 2022. Disponível em: https://www.gov.br/conitec/pt-br/midias/consultas/relatorios/2022/20220526_ddt_mieloma_multiplo_cp.pdf. Acesso em: 12 nov. 2024.

CARDOSO, M. DE F. A. et al. Prevenção e controle das seqüelas bucais em pacientes irradiados por tumores de cabeça e pescoço. Radiologia Brasileira, v. 38, n. 2, p. 107–115, abr. 2005.

FERREIRA, S. O.; CARDOSO, P.; RIBEIRO, U. Osteonecrose dos maxilares associada à bifosfonatos: importância do cirurgião dentista. Revista Saúde - UNG-Ser, v. 12, n. 1(ESP), p. 18–18, 2018.

FREIRE, A. C. et al. Análise dos fatores predisponentes de pacientes que adquiriram infecção após transplante de medula óssea. CuidArte, Enferm, p. 262-268, 2023.

GOH, E. Z. et al. The dental management of patients irradiated for head and neck cancer. British Dental Journal, v. 234, n. 11, p. 800–804, 1 jun. 2023.

KAZANDJIAN, D. Multiple myeloma epidemiology and survival: A unique malignancy. Seminars in oncology, v. 43, n. 6, p. 676–681, 2016.

LUCON, R. P. Bisfosfonatos e osteonecrose dos maxilares: aspectos gerais e importância para o cirurgião dentista. (Doctoral dissertation, SLMANDIC), 2010.

MIRANDA, B. P.; MIRANDA, H. P. Uso de bifosfonatos e o risco de osteonecrose da mandíbula. Revista Eletrônica Acervo Saúde, v. 24, n. 10, p. e15691–e15691, 13 out. 2024.

NICOLATOU-GALITIS, O. et al. Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, v. 127, n. 2, p. 117–135, fev. 2019.

RODRIGUES, R. D.; NETO, J. N. N.; CARVALHO DANTAS DE OLIVEIRA, J. F.

Atendimento odontológico em paciente portador de mieloma múltiplo: relato de caso.

Journal of Dentistry & Public Health, v. 9, n. 2, p. 156–160, 29 jun. 2018.

SANTOS, P. S. S. et al. Osteonecrose maxilar em pacientes portadores de doenças neoplásicas sob uso de bisfosfonatos. Revista brasileira de hematologia e hemoterapia, v. 30, n. 6, p. 501–504, 2008.